Phase 1b-2 Study of Niraparib Combina... - Advanced Prostate...

Advanced Prostate Cancer

22,373 members28,135 posts

Phase 1b-2 Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant PC

scarlino profile image
12 Replies

Anyone have any experience with this clinical trial? If my PSA continues to increase my doctor is interested in my signing up for this. I’ve been on the Prednisone, Zytiga, Apalutemide Clinical trial for 16 months but, alas, the s.o.b. Is starting to win again. I’m treated at MD Anderson in Houston and I would only be the second guinea pig for this.

Written by
scarlino profile image
scarlino
To view profiles and participate in discussions please or .
Read more about...
12 Replies
gusgold profile image
gusgold

Darolutamide maybe somewhat better but once the beast figures out how to beat Zytiga/Xtandi you are on the express train to hell

scarlino profile image
scarlino in reply togusgold

I guess it’s a good thing I’m going to heaven!!

Schwah profile image
Schwah in reply togusgold

One thing I love about this site is the positivity and cordial discourse.. It’s good for all of us. Those type of comments are really counter productive in my opinion.

Schwah.

Kevinski65 profile image
Kevinski65 in reply togusgold

Use , ' thunder of God root extract' and Xtandi will last longer.

Kevinski65 profile image
Kevinski65 in reply toKevinski65

Also Xtandi or Zytiga need to be used with Lupron or degarilix or some other androgen antagonist.

scarlino profile image
scarlino in reply toKevinski65

I have had Lupron continuously since cancer returned since 2015. Also Prednisone with the Zytiga and Apalutemide together as part of a clinical trial. That combination got my PSA down to 0.6. Stayed there for 15 months until it jumped to 2 last week. 15 months is nearly three times as long as any of the other treatment plans I’ve been on. Other than the tumor in the prostate I have only had pelvic lymph node involvement.

ctarleton profile image
ctarleton

If this is the link describing the Trial, it looks like only MD Anderson, and Thomas Jefferson University in Philadelphia have started recruiting in the USA, and only 3 sites in Spain have started recruiting elsewhere in the world. Considering that this Trial is only looking for 60 participants, total, there may not be many others yet with any direct experience.

clinicaltrials.gov/ct2/show...

I would want to familiarize myself with the existing Full Prescribing Information for Niraparib while considering the decision, and whatever known/documented things are noted from prior studies. Maybe ask some more questions

accessdata.fda.gov/drugsatf...

"Eyes wide open".

Good Luck in whatever you may decide.

Charles

scarlino profile image
scarlino in reply toctarleton

Thank you Charles. I have a copy of the Clinical Trial details and the list of side affects. I would prefer a study that has a good sized population pool in place, but this is a study including immunotherapy too so I am I interested from that perspective. I appreciate your response!

Cmdrdata profile image
Cmdrdata

Howdy Scarlino, could you please PM me through chat about your doctor’s name at MDA? My doctor at Memorial Hermann has been mostly absent due to his own health issue for over a year, although I consider him to be one of the most outstanding PC researcher.

On your clinical trials I found three clinical trials:

1. NCT 03431350 (JNJ-63723283 + Niraparib) - recruiting state (prostate)

2. NCT035511782(JNJ-63723283 + Apalutamide) - not yet open (prostate)

3. NCT03357952 (JNJ-63723283 + Daratumumab) - not yet open (myeloma)

4. There is a fourth one, using the same JNJ63723283 targeted for urothelial cancer).

So it seemed that the key trial is JNJ-63723283, and this is an anti-programmed death monoclonal antibody drug, which I am interested in. I am at the cusp of mCRPC. Thanks

scarlino profile image
scarlino in reply toCmdrdata

Hi, my doctor is Dr. Zarita at MD Anderson. I like him. He is very precise in his explanations and takes the time to compare my scans to relay any findings. I haven’t met a poor doctor there yet. They are all invested in research as well as clinical treatment.

MontyB profile image
MontyB

Hello scarlino,

Did you sign up for this trial ? Yesterday my doctor recommended it to me.

Take Care,

Monty

scarlino profile image
scarlino in reply toMontyB

No they are doing a lymph node biopsy on me today, but that is my MO requesting. I believe because they have to wait until I stop medications for 30 days and a spot becomes available. Those two things need to work out schedule-wise in order for me to do it.

Not what you're looking for?

You may also like...

Phase 1b-2 Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant PC....anyone doing this one?

Is anyone taking part in or have experience with this clinical trial? Scarlino asked about this 4...
MontyB profile image

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

Hello, I am a participant in the clinical trial NCT04221542, in the Vall d'Hebron Hospital in...
jrodrig profile image

Combination of Statin/Vitamin D and Metastatic Castration-Resistant Prostate Cancer (CRPC) ...

New study below [1]. Note: AA = Abiraterone acetate/Zytiga "We conducted a post hoc analysis of...
pjoshea13 profile image

ProSTAR: A Phase 1b/2 Study of CPI-1205, a Small Molecule

Sadly, I am castrate resistant we have numerous Mets to ribs and spine. I have been on Zytiga...

Veru Reports Positive Clinical Results from VERU-111 Phase 1b/2 Trial in Men with Metastatic Castration-Resistant Prostate Cancer, Advancing

This is what I was working on getting for my husband the day before he died last month. They're...
JLS1 profile image